Literature DB >> 16503844

Adherence to nicotine replacement patch therapy in cardiovascular patients.

Louise C W Wiggers1, Ellen M A Smets, Frans J Oort, Marja N Storm-Versloot, Hester Vermeulen, Lucas B M van Loenen, Ron J G Peters, Hanneke C J M de Haes, Dink A Legemate.   

Abstract

Nicotine Replacement Therapy (NRT) is the most frequently used pharmacological intervention for smoking cessation. Research on the effect of NRT showed serious nonadherence among users. We investigated adherence to NRT in cardiovascular patients. A number of 174 outpatients (N = 174), who smoked > 5 cigarettes a day, received free patches and intensive instructions from nurses. Questionnaires were sent to patients assessing patient characteristics, adherence to a 7-8 weeks time frame and appliance instructions, side effects/withdrawal symptoms, and reasons for nonadherence. Only 38% of the patients was adherent to the time frame. Appliance instructions were followed in 76-96% of the cases, except for smoking; 50% continued to smoke during NRT. In conclusion, despite considerable attention to appliance instructions, access to free patches and additional behavioral support, adherence to NRT in these patients is rather low.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16503844     DOI: 10.1207/s15327558ijbm1301_10

Source DB:  PubMed          Journal:  Int J Behav Med        ISSN: 1070-5503


  40 in total

1.  Ability of smokers to reduce their smoking and its association with future smoking cessation.

Authors:  J R Hughes; K M Cummings; A Hyland
Journal:  Addiction       Date:  1999-01       Impact factor: 6.526

2.  Self-reported abstinence effects in the first month after smoking cessation.

Authors:  M M Ward; G E Swan; L M Jack
Journal:  Addict Behav       Date:  2001 May-Jun       Impact factor: 3.913

3.  Effectiveness of a minimal contact smoking cessation program for Dutch general practitioners: a randomized controlled trial.

Authors:  M E Pieterse; E R Seydel; H DeVries; A N Mudde; G J Kok
Journal:  Prev Med       Date:  2001-02       Impact factor: 4.018

4.  Dose-related cardiovascular and endocrine effects of transdermal nicotine.

Authors:  S Zevin; P Jacob; N L Benowitz
Journal:  Clin Pharmacol Ther       Date:  1998-07       Impact factor: 6.875

5.  Women's Initiative for Nonsmoking (WINS V): under-use of nicotine replacement therapy.

Authors:  Romy Mahrer-Imhof; Erika Sivarajan Froelicher; Wen-Wen Li; Kathleen M Parker; Neal Benowitz
Journal:  Heart Lung       Date:  2002 Sep-Oct       Impact factor: 2.210

6.  A double-blind trial of a 16-hour transdermal nicotine patch in smoking cessation.

Authors:  P Tønnesen; J Nørregaard; K Simonsen; U Säwe
Journal:  N Engl J Med       Date:  1991-08-01       Impact factor: 91.245

7.  The Hawthorne effect in the measurement of adolescent smoking.

Authors:  M Murray; A V Swan; S Kiryluk; G C Clarke
Journal:  J Epidemiol Community Health       Date:  1988-09       Impact factor: 3.710

8.  The safety of transdermal nicotine as an aid to smoking cessation in patients with cardiac disease.

Authors:  A M Joseph; S M Norman; L H Ferry; A V Prochazka; E C Westman; B G Steele; S E Sherman; M Cleveland; D O Antonuccio; D O Antonnucio; N Hartman; P G McGovern
Journal:  N Engl J Med       Date:  1996-12-12       Impact factor: 91.245

9.  A minimal-contact intervention for cardiac inpatients: long-term effects on smoking cessation.

Authors:  Catherine Bolman; Hein de Vries; Gerard van Breukelen
Journal:  Prev Med       Date:  2002-08       Impact factor: 4.018

10.  Smoking cessation interventions in cardiovascular patients.

Authors:  L C W Wiggers; E M A Smets; J C J M de Haes; R J G Peters; D A Legemate
Journal:  Eur J Vasc Endovasc Surg       Date:  2003-11       Impact factor: 7.069

View more
  17 in total

1.  Predictors of adherence to nicotine gum and counseling among African-American light smokers.

Authors:  Kolawole S Okuyemi; Hui Zheng; Hongfei Guo; Jasjit S Ahluwalia
Journal:  J Gen Intern Med       Date:  2010-05-21       Impact factor: 5.128

Review 2.  Pharmacotherapy for smoking cessation: current advances and research topics.

Authors:  Tobias Raupach; Constant P van Schayck
Journal:  CNS Drugs       Date:  2011-05       Impact factor: 5.749

3.  Adherence to and consumption of nicotine replacement therapy and the relationship with abstinence within a smoking cessation trial in primary care.

Authors:  Gareth J Hollands; Stephen Sutton; Máirtín S McDermott; Theresa M Marteau; Paul Aveyard
Journal:  Nicotine Tob Res       Date:  2013-02-19       Impact factor: 4.244

Review 4.  Individual behavioural counselling for smoking cessation.

Authors:  Tim Lancaster; Lindsay F Stead
Journal:  Cochrane Database Syst Rev       Date:  2017-03-31

5.  Predictors of adherence to nicotine replacement therapy: Machine learning evidence that perceived need predicts medication use.

Authors:  Nayoung Kim; Danielle E McCarthy; Wei-Yin Loh; Jessica W Cook; Megan E Piper; Tanya R Schlam; Timothy B Baker
Journal:  Drug Alcohol Depend       Date:  2019-10-25       Impact factor: 4.492

6.  Enhancing tobacco quitline effectiveness: identifying a superior pharmacotherapy adjuvant.

Authors:  Stevens S Smith; Paula A Keller; Kate H Kobinsky; Timothy B Baker; David L Fraser; Terry Bush; Brooke Magnusson; Susan M Zbikowski; Timothy A McAfee; Michael C Fiore
Journal:  Nicotine Tob Res       Date:  2012-09-19       Impact factor: 4.244

Review 7.  Consideration of sex in clinical trials of transdermal nicotine patch: a systematic review.

Authors:  Andrea H Weinberger; Philip H Smith; Mira Kaufman; Sherry A McKee
Journal:  Exp Clin Psychopharmacol       Date:  2014-08-18       Impact factor: 3.157

8.  Immediate versus delayed quitting and rates of relapse among smokers treated successfully with varenicline, bupropion SR or placebo.

Authors:  David Gonzales; Douglas E Jorenby; Thomas H Brandon; Carmen Arteaga; Theodore C Lee
Journal:  Addiction       Date:  2010-09-01       Impact factor: 6.526

9.  RESPONSE study: Randomised Evaluation of Secondary Prevention by Outpatient Nurse SpEcialists: Study design, objectives and expected results.

Authors:  H T Jørstad; A M W Alings; A H Liem; C von Birgelen; J G P Tijssen; C J de Vries; D J A Lok; J A Kragten; R J G Peters
Journal:  Neth Heart J       Date:  2009-09       Impact factor: 2.380

10.  Low incidence of adverse events following varenicline initiation among opioid dependent smokers with comorbid psychiatric illness.

Authors:  Shadi Nahvi; Bryan Wu; Kimber P Richter; Steven L Bernstein; Julia H Arnsten
Journal:  Drug Alcohol Depend       Date:  2013-01-17       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.